| Followers | 200 |
| Posts | 25596 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Sunday, May 02, 2021 3:39:07 PM
I do not know about a “secret BLA”, they will apply, and it may have already started in my opinion. It’s what I would do in their situation. I think they will proceed with the process ASAP, because that is what makes the most sense. I do not think “messiness” has anything to do with it. I think it was a trial that followed FDA requirements and guidelines including the increases in numbers and other adaptations, up to and including the update to the SAP. Period.
I think the fact that we are still discussing it after shorts thought they had finished the company off, has some people upset. Otherwise, why would people care so much that this tiny company is proceeding, if “the trial is so messed up” that they will never actually apply? Why, if you’re not invested, would you even care in that instance since you are therefore complaining really that they only intend to get the data together and publish it... obviously you do not believe that. If you did, you’d not waste your days, weekends, weekdays, evenings and holidays here.
Clearly you have just said one thing but your activity says the other. With an exclamation point.
I think the fact that we are still discussing it after shorts thought they had finished the company off, has some people upset. Otherwise, why would people care so much that this tiny company is proceeding, if “the trial is so messed up” that they will never actually apply? Why, if you’re not invested, would you even care in that instance since you are therefore complaining really that they only intend to get the data together and publish it... obviously you do not believe that. If you did, you’d not waste your days, weekends, weekdays, evenings and holidays here.
Clearly you have just said one thing but your activity says the other. With an exclamation point.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
